Torsten Peter Vahl MD
Adult Congenital Heart Disease, Interventional Cardiology
Physician
177 Fort Washington Ave5TH floor 5C501New York, NY 10032
Overview of Dr. Vahl
Dr. Torsten Vahl is a cardiologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and NewYork-Presbyterian/Lawrence Hospital. He received his medical degree from Philipps University of Marburg Faculty of Medicine and has been in practice 19 years. He is one of 719 doctors at New York-Presbyterian Hospital and one of 338 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Cardiology. He has more than 100 publications and over 500 citings.
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 2008 - 2012- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2006 - 2008
Philipps University of Marburg Faculty of MedicineClass of 1998
Certifications & Licensure
NY State Medical License 2011 - 2027
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
Publications & Presentations
PubMed
- Transseptal Transcatheter Mitral Valve Replacement With a Novel Bioprosthesis in a Patient With Challenging Anatomy.Tamaz Shaburishvili, Lauren S Ranard, Teona Zirakashvili, Stefano Stella, Torsten P Vahl
JACC. Case Reports. 2025-08-20 - Transcatheter Tricuspid Valve Replacement Beyond Boundaries.Robin Le Ruz, Isaac George, Vratika Agarwal, Tamim Nazif, Mark Lebehn
JACC. Case Reports. 2025-08-13 - The role of cardiac surgeons in transcatheter structural heart disease interventions: The evolution of cardiac surgery.Luigi Pirelli, Kendra J Grubb, Isaac George, Andrew M Goldsweig, Tamim M Nazif
The Journal of Thoracic and Cardiovascular Surgery. 2025-08-01
Journal Articles
- Focus on Trends in Surgical and Transcatheter Aortic Valve Replacement Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Prior Cardiac Surgery in...Vinod H Thourani, Lars Svensson, Kevin L Greason, Torsten P Vahl, Rakesh M Suri, Martin B Leon, Susheel K Kodali, Tamim Nazif, ScienceDirect
Lectures
- Case: JenaValve for Pure Aortic RegurgitationCRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
- The Anatomically 'Correct' JenaValve TAVR System – Best for Pure AR and Low Coronaries – EFS ResultsCRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
- Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary OcclusionCRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
- Join now to see all
Press Mentions
ESC/EACTS Valvular Heart Disease Guidelines Address TAVR for Aortic RegurgitationSeptember 12th, 2025- JenaValve Announces First Patient Enrolled in ARTIST Randomized Controlled Trial (RCT) Evaluating the Trilogy™ System in Aortic Regurgitation (AR)July 14th, 2025
- ALIGN-AR at 2 Years Shows Promise for TAVI with Trilogy in Aortic RegurgitationOctober 29th, 2024
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
